参考文献/References:
［1］Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception［J］. Drugs,2011,71(8): 969-980.
［2］ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices［J］. Obstet Gynecol,2011,118(1): 184-196.
［3］Sabbioni L, Petraglia F, Luisi S. Non-contraceptive benefits of intrauterine levonorgestrel administration: why not［J］. Gynecol Endocrinol,2017,33(11): 822-829.
［4］Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials ［J］. Fertil Steril,2009,91(5): 1646-1653.
［5］Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment ［J］. Nat Rev Endocrinol,2014,10 (5): 261-275.
［6］Máximo MM, Silva PS, Vieira CS, et al. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women ［J］. Fertil Steril, 2015,104(5): 1182-1189.
［7］Sauvan M, Chabbert-Buffet N, Geoffron S, et al. Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines ［J］. Gynecol Obstet Fertil Senol, 2018,46(3): 264-266.
［8］Bitzer J, Heikinheimo O, Nelson AL, et al. Medical management of heavy menstrual bleeding: a comprehensive review of the literature［J］. Obstet Gynecol Surv,2015,70 (2): 115-130.
［9］Bhatia P, Nangia S, Aggarwal S, et al. Implanon: subdermal single rod contraceptive implant［J］. J Obstet Gynaecol India,2011,61(4): 422-425.
［10］阎华, 王红, 杨立群, 等. 依托孕烯皮埋剂与左炔诺孕酮治疗子宫腺肌病的对比研究 ［J］. 蚌埠医学院学报,2018,43(12): 1561-1564.
［11］Eggebroten JL, Sanders JN, Turok DK. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis［J］. Am J Obstet Gynecol,2017,217(1): 51.e1-51.e7.
［12］The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia［J］. Obstet Gynecol,2015,125(5): 1272-1278.
［13］Kim MK, Seong SJ, Kim JW, et al. Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: A Korean gynecologic-oncology group study［J］. Int J Gynecol Cancer,2016,26(4): 711-715.
［14］Hannan NJ, Jones RL, Critchley HO, et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling ［J］. J Clin Endocrinol Metab,2004,89(12): 6119-6129.
［15］Mascarenhas L, Van Beek A, Bennink HC, et al. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK［J］. Hum Reprod,1998,13(11): 3057-3060.
［16］Apter D, Briggs P, Tuppurainen M, et al. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant ［J］. Fertil Steril,2016,106(1): 151-157.e5.
［17］Vincent AJ, Salamonsen LA. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives ［J］. Hum Reprod,2000,15 (Suppl 3): 135-143.
［18］Guiahi M, McBride M, Sheeder J, et al. Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: A randomized controlled trial ［J］. Obstet Gynecol,2015,126(3): 508-513.
［19］Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon on menstrual bleeding patterns ［J］. Eur J Contracept Reprod Health Care,2008,13(Suppl 1): 13-28.
［20］Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel ［J］. Contraception,2007,75(6 Suppl): S93-98.
［21］Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use ［J］. Am J Obstet Gynecol,2017,216(5): 443-450.
相似文献/References:
[1]程玉梅,魏薇.左炔诺孕酮宫内缓释系统的非避孕作用的临床研究[J].中国计划生育和妇产科,2010,(03):0.
[2]尚思慧,林琬君.左炔诺孕酮宫内缓释系统的非避孕应用[J].中国计划生育和妇产科,2011,(06):0.
SHANG Si-hui,LIN Wan-jun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(10):0.
[3]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[4]宋芷霜,郭宝芝,刘爱珍,等.左炔诺孕酮宫内缓释系统预防子宫内膜息肉复发的临床观察[J].中国计划生育和妇产科,2015,(02):0.
SONG Zhi-shuang,GUO Bao-zhi,LIU Ai-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[5]程金花,孙德蓉,周芳,等.宫腔镜下电切术联合左炔诺孕酮宫内缓释系统治疗子宫肌瘤的效果观察[J].中国计划生育和妇产科,2015,(05):0.
CHENG Jin-hua,SUN De-rong,ZHOU Fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(10):0.
[6]郭清,徐锋,丁珍珍,等.高强度聚焦超声治疗子宫腺肌病3种方案的疗效对比研究[J].中国计划生育和妇产科,2016,(09):0.
GUO Qing,XU Feng,DING Zhen-zhen,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(10):0.
[7]于丽霞,徐琳瑛.高强度聚焦超声联合左炔诺孕酮宫内缓释系统对子宫腺肌病患者血清CA 125、抗子宫内膜抗体、血红蛋白及卵巢功能的影响[J].中国计划生育和妇产科,2019,(4):33.
YU Li-xia,XU LIN-ying*.Effect of high intensity focused ultrasound combined with levonorgestrel releasing intrauterine system on serum CA 125, EMAb, hemoglobin and ovarian function in patients with adenomyosis[J].Chinese Journal of Family Planning & Gynecotokology,2019,(10):33.